BioMarin Pharmaceutical | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 861M 2.77B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



BioMarin Pharmaceutical Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.